An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis

Assess the sensitivity of the Magnetic Resonance Disease Severity Scale (MRDSS), based on cerebral lesions and atrophy, for treatment monitoring of glatiramer acetate (GA) in relapsing-remitting multiple sclerosis (MS). This retrospective non-randomized pilot study included patients who started dail...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Gloria, Tauhid, Shahamat, Dupuy, Sheena L., Tummala, Subhash, Khalid, Fariha, Healy, Brian C., Bakshi, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785194/
https://www.ncbi.nlm.nih.gov/pubmed/26754005
http://dx.doi.org/10.1007/s00415-015-8009-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785194/
https://www.ncbi.nlm.nih.gov/pubmed/26754005
http://dx.doi.org/10.1007/s00415-015-8009-8

Ejemplares similares